These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35708221)

  • 1. On the choice of timescale for other cause mortality in a competing risk setting using flexible parametric survival models.
    Skourlis N; Crowther MJ; Andersson TM; Lambert PC
    Biom J; 2022 Oct; 64(7):1161-1177. PubMed ID: 35708221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study.
    Zelic R; Zugna D; Bottai M; Andrén O; Fridfeldt J; Carlsson J; Davidsson S; Fiano V; Fiorentino M; Giunchi F; Grasso C; Lianas L; Mascia C; Molinaro L; Zanetti G; Richiardi L; Pettersson A; Akre O
    Am J Epidemiol; 2019 Jun; 188(6):1165-1173. PubMed ID: 30976789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flexible parametric modelling of the cause-specific cumulative incidence function.
    Lambert PC; Wilkes SR; Crowther MJ
    Stat Med; 2017 Apr; 36(9):1429-1446. PubMed ID: 28008649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct likelihood inference on the cause-specific cumulative incidence function: A flexible parametric regression modelling approach.
    Mozumder SI; Rutherford M; Lambert P
    Stat Med; 2018 Jan; 37(1):82-97. PubMed ID: 28971494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis for aggregated survival data with competing risks: a parametric approach using cumulative incidence functions.
    Bonofiglio F; Beyersmann J; Schumacher M; Koller M; Schwarzer G
    Res Synth Methods; 2016 Sep; 7(3):282-93. PubMed ID: 26387882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct likelihood inference and sensitivity analysis for competing risks regression with missing causes of failure.
    Moreno-Betancur M; Rey G; Latouche A
    Biometrics; 2015 Jun; 71(2):498-507. PubMed ID: 25761785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models.
    Mozumder SI; Rutherford MJ; Lambert PC
    BMC Med Res Methodol; 2021 Mar; 21(1):52. PubMed ID: 33706711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.
    Schuster NA; Hoogendijk EO; Kok AAL; Twisk JWR; Heymans MW
    J Clin Epidemiol; 2020 Jun; 122():42-48. PubMed ID: 32165133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing risk bias in Kaplan-Meier risk estimates can be corrected.
    van Walraven C; Hawken S
    J Clin Epidemiol; 2016 Feb; 70():101-5. PubMed ID: 26327491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constrained parametric model for simultaneous inference of two cumulative incidence functions.
    Shi H; Cheng Y; Jeong JH
    Biom J; 2013 Jan; 55(1):82-96. PubMed ID: 23090878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis in the presence of competing risks.
    Zhang Z
    Ann Transl Med; 2017 Feb; 5(3):47. PubMed ID: 28251126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes of death in women with breast cancer: a risks and rates study on a population-based cohort.
    Contiero P; Boffi R; Borgini A; Fabiano S; Tittarelli A; Mian M; Vittadello F; Epifani S; Ardizzone A; Cirilli C; Boschetti L; Marguati S; Cascone G; Tumino R; Fanetti AC; Giumelli P; Candela G; Scuderi T; Castelli M; Bongiorno S; Barigelletti G; Perotti V; Veronese C; Turazza F; Crivaro M; Tagliabue G;
    Front Oncol; 2023; 13():1270877. PubMed ID: 38023134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. stpm2cr: A flexible parametric competing risks model using a direct likelihood approach for the cause-specific cumulative incidence function.
    Mozumder SI; Rutherford MJ; Lambert PC
    Stata J; 2017; 17(2):462-489. PubMed ID: 30305806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint modeling of longitudinal and competing-risk data using cumulative incidence functions for the failure submodels accounting for potential failure cause misclassification through double sampling.
    Thomadakis C; Meligkotsidou L; Yiannoutsos CT; Touloumi G
    Biostatistics; 2023 Dec; 25(1):80-97. PubMed ID: 36331265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexible modeling of competing risks in survival analysis.
    Belot A; Abrahamowicz M; Remontet L; Giorgi R
    Stat Med; 2010 Oct; 29(23):2453-68. PubMed ID: 20645282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved confidence intervals for a difference of two cause-specific cumulative incidence functions estimated in the presence of competing risks and random censoring.
    Scosyrev E
    Biom J; 2020 Oct; 62(6):1394-1407. PubMed ID: 32227361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
    Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
    Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the adjusted cause-specific cumulative probability using flexible regression models for the cause-specific hazards.
    Kipourou DK; Charvat H; Rachet B; Belot A
    Stat Med; 2019 Sep; 38(20):3896-3910. PubMed ID: 31209905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction.
    Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Frigerio M
    J Clin Epidemiol; 2018 Nov; 103():31-39. PubMed ID: 30009940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.